The target of rapamycin (TOR) signal transduction network monitors intra-and extracellular conditions that favor cell growth. Research during the last decade has revealed a modular structure of the TOR signaling network. Each signaling module senses a particular set of signals from the cellular milieu and exerts regulatory control towards TOR activity. The TOR pathway responds to growth factor signals, nutrient availability, and cellular stresses like hypoxia and energy stress. The signaling modules and their molecular components constituting the TOR network are remarkably conserved in both sequence and function across species. In yeast, roundworms, flies, and mice, the TOR pathway has been shown to regulate lifespan. Correspondingly, genetic, dietary or pharmacological manipulation of individual signaling modules as well as TOR activity itself extends lifespan in these model organisms. We discuss the potential impact of manipulating TOR activity for human health and lifespan.
Introduction
The achievements of medicine and public health over the past century and a half have resulted in an increased life expectancy, most notably in developed countries. Since 1840, lifespan expectancy has increased nearly linearly without showing signs of slowing down (Christensen et al., 2009) . Much of this increase in the early part of the 20th century was due to improvements in infant and childhood survival. However, since the midpoint of the last century, lifespan improvements have largely been due to a reduction of mortality among the elderly. The probability of dying within a year for 80-and 90-year olds has steadily declined since 1950. This increase in lifespan, accompanied by a decrease in fecundity, has lead to an aging population in many developed countries (Christensen et al., 2009) .
Along with an aging population comes an increase in age-related diseases, such as cancer, cardiovascular disease, type 2 diabetes, osteoporosis, and Alzheimer's, among many others (Christensen et al., 2009; Drachman, 2006; Holroyd et al., 2008) . As a result, ଝ A contribution from the Longevity Consortium, a multi-investigator research initiative supported by NIH contract 5 U19 AG023122. identifying effective methods to treat or prevent these diseases has become a public health priority. The observation that lifespan and many age-related diseases have a substantial heritable component in humans has encouraged the search for the genetic underpinnings of these processes (Fallin and Matteini, 2009 ). Data from model organisms have also indicated that the genetic pathways regulating lifespan exhibit remarkable functional conservation across multiple species, possibly even extending to humans (Bell et al., 2009; Partridge, 2009) . The identification of genes regulating lifespan can reveal the biological basis of age-related diseases, potentially leading to better prognosis and therapies. In this review, we summarize evidence from model organisms that lifespan can be influenced by the TOR pathway, an ancient genetic pathway functionally conserved across many species. The TOR pathway plays a well established role in growth control and lifespan. In yeast, roundworms, flies, and mice, the TOR pathway has been shown to regulate lifespan (Kenyon, 2005) . Deregulation of TOR signaling has also been consistently observed in age-related diseases such as type 2 diabetes and a wide variety of cancers (Brugge et al., 2007; Guertin and Sabatini, 2007) . In this review, we first describe the regulatory structure of the TOR signaling network and emphasize its modularity. Second, we turn to the genetic evidence from model organisms associating each signaling module with lifespan control. We will conclude by discussing the promises and complications for future studies of the TOR pathway's role in human longevity.
